From Evan Harris <[email protected]>
Subject Pelosi’s Drug Price Controls Are Dangerous—But So Are Trump’s
Date February 3, 2020 7:59 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
PRI's Focus on Health Care

View this email in your browser ([link removed])

Pelosi’s Drug Price Controls Are Dangerous—But So Are Trump’s

Forbes | Sally C. Pipes
January 31, 2020

These price controls—enforced by referencing the prices in the six countries—could reduce drug companies’ revenues by $1 trillion over the next decade, according to the Congressional Budget Office. And since drug firms generally devote 15 to 20 percent of revenues to creating new medicines, that means they’ll spend about $200 billion less on research and development.
Read more. . . ([link removed])
[link removed]
Now an Amazon.com #1 bestseller among policy books (health law books).

While Americans pine for ‘Medicare for all,’ Canadians look for US-style private insurance

The Washington Examiner | Sally C. Pipes
February 3, 2020

That majority would be wise to take a look across our northern border. Waits for care in Canada’s government-run health insurance system, the closest analog to “Medicare for all” in the world, are spiraling. The remedy for those waits, according to a new report from the Vancouver-based Fraser Institute? A dose of U.S.-style private insurance.
Read more. . . ([link removed])

American health care needs more competition, not less, to bring down prices

The Tennessean | Sally C. Pipes
February 3, 2020

Hospital systems have steadily bought out their competition. Consider one recent study from the Health Care Cost Institute, which analyzed hospital markets in 112 metro areas in 43 states. Between 2012 and 2016, the hospital markets in more than two-thirds of these areas grew more concentrated. By 2016, 72% of metro areas qualified as “highly concentrated,” meaning that just a handful of hospital systems handled nearly all admissions in the area.

Read more. . . ([link removed])

States Should Not Resurrect The Individual Mandate

Forbes | Sally C. Pipes
February 3, 2020

The individual mandate was, unsurprisingly, enormously unpopular. Six in ten Americans had an unfavorable view of it from essentially the moment it was enshrined into law, according to polling from the Kaiser Family Foundation. The public saw it as an unprecedented intrusion into their personal lives. Never before had the federal government forced private citizens to purchase a particular good.
Read more. . . ([link removed])

============================================================
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
** ([link removed])
Copyright © 2020 *Pacific Research Institute*, All rights reserved.
You are receiving this email because you opted in via our website.

Our mailing address is:
101 Montgomery Street, Suite 1300, San Francisco, CA 94104

Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
.
Screenshot of the email generated on import

Message Analysis